Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
71
NUVB Quote, Financials, Valuation and Earnings
Last price:
$9.42
Seasonality move
:
-4.64%
Day range:
$9.26 - $9.56
52-week range:
$1.54 - $9.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
119.37x
P/B ratio:
9.89x
Volume:
3.6M
Avg. volume:
8.8M
1-year change:
233.33%
Market cap:
$3.2B
Revenue:
$7.9M
EPS (TTM):
-$0.64
Earnings Data
Next earnings date for NUVB
Mar 05
2026
Most recent earnings per share
-$0.16
Missed by $0.01
(Nov 3/2025)
Consensus Estimate
-$0.15
(Nov 3/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NUVB Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/05/2026 | Q4 | $32.6M | -- | -- | -$0.04 | -- |
| 11/03/2025 | Q3 | $6.9M | $13.1M | -$0.16 | -$0.15 | -$0.01 |
| 08/07/2025 | Q2 | $416.7K | $4.8M | -$0.17 | -$0.14 | -$0.03 |
| 05/07/2025 | Q1 | $357.1K | $3.1M | -$0.16 | -$0.12 | -$0.04 |
| 03/06/2025 | Q4 | -- | $5.7M | -$0.15 | -$0.12 | -$0.03 |
| 11/06/2024 | Q3 | -- | $727K | -$0.15 | -$0.10 | -$0.05 |
| 08/05/2024 | Q2 | -- | $1.4M | -$1.89 | -$0.05 | -$1.84 |
| 05/14/2024 | Q1 | -- | -- | -$0.07 | -$0.05 | -$0.02 |
| 02/29/2024 | Q4 | -- | -- | -$0.06 | -$0.08 | $0.02 |
| 11/02/2023 | Q3 | -- | -- | -$0.09 | -- | -- |
| 08/03/2023 | Q2 | -- | -- | -$0.09 | -- | -- |
| 05/04/2023 | Q1 | -- | -- | -$0.10 | -- | -- |
| 03/15/2023 | Q4 | -- | -- | -$0.10 | -- | -- |
| 11/03/2022 | Q3 | -- | -- | -$0.12 | -- | -- |
| 08/04/2022 | Q2 | -- | -- | -$0.16 | -- | -- |
| 05/09/2022 | Q1 | -- | -- | -$0.10 | -- | -- |
| 02/28/2022 | Q4 | -- | -- | -$0.12 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$0.11 | -- | -- |
| 08/12/2021 | Q2 | -- | -- | -$0.09 | -- | -- |
| 05/17/2021 | Q1 | -- | -- | -$0.12 | -- | -- |
| 03/11/2021 | Q4 | -- | -- | -$0.11 | -- | -- |
| 11/16/2020 | Q3 | -- | -- | -$0.10 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.47 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.47 | -- | -- |
Nuvation Bio, Inc. Earnings Questions
-
How Much did Nuvation Bio, Inc. Generate in Revenue Last Quarter?
Nuvation Bio, Inc. reported $13.1M worth of top line sales in its most recent quarter.
-
Did Nuvation Bio, Inc. Beat Earnings Last Quarter?
Nuvation Bio, Inc. announced earnings per share of -$0.16 which represents a miss of analyst forecast a -$0.15 per share.
-
Is Nuvation Bio, Inc. Profitable?
Nuvation Bio, Inc. reported $9.2M that represents $0.03 per share over the last quarter.
-
What is the Analyst Consensus for Nuvation Bio, Inc. EPS Next Year?
Nuvation Bio, Inc.'s earnings are forecast to decrease from -$2.11 per share to -$0.45 per share next year representing a decrease of -78.7%.
-
When is Nuvation Bio, Inc.'s Earnings Date?
Nuvation Bio, Inc.'s next earnings date is March 5, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
